EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression

Bibliographic Details
Main Authors: C. Antin, A. Tauziède-Espariat, M.-A. Debily, D. Castel, J. Grill, M. Pagès, O. Ayrault, F. Chrétien, A. Gareton, F. Andreiuolo, E. Lechapt, P. Varlet
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Acta Neuropathologica Communications
Online Access:http://link.springer.com/article/10.1186/s40478-020-01056-8
id doaj-064e7e5960b84514a87dcc26309058a3
record_format Article
spelling doaj-064e7e5960b84514a87dcc26309058a32020-11-25T04:07:22ZengBMCActa Neuropathologica Communications2051-59602020-11-01811510.1186/s40478-020-01056-8EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpressionC. Antin0A. Tauziède-Espariat1M.-A. Debily2D. Castel3J. Grill4M. Pagès5O. Ayrault6F. Chrétien7A. Gareton8F. Andreiuolo9E. Lechapt10P. Varlet11Department of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-SaclayUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-SaclayUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-SaclayDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalCNRS UMR, INSERM, Institut Curie, PSL Research UniversityDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne HospitalDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospitalhttp://link.springer.com/article/10.1186/s40478-020-01056-8
collection DOAJ
language English
format Article
sources DOAJ
author C. Antin
A. Tauziède-Espariat
M.-A. Debily
D. Castel
J. Grill
M. Pagès
O. Ayrault
F. Chrétien
A. Gareton
F. Andreiuolo
E. Lechapt
P. Varlet
spellingShingle C. Antin
A. Tauziède-Espariat
M.-A. Debily
D. Castel
J. Grill
M. Pagès
O. Ayrault
F. Chrétien
A. Gareton
F. Andreiuolo
E. Lechapt
P. Varlet
EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
Acta Neuropathologica Communications
author_facet C. Antin
A. Tauziède-Espariat
M.-A. Debily
D. Castel
J. Grill
M. Pagès
O. Ayrault
F. Chrétien
A. Gareton
F. Andreiuolo
E. Lechapt
P. Varlet
author_sort C. Antin
title EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
title_short EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
title_full EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
title_fullStr EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
title_full_unstemmed EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
title_sort ezhip is a specific diagnostic biomarker for posterior fossa ependymomas, group pfa and diffuse midline gliomas h3-wt with ezhip overexpression
publisher BMC
series Acta Neuropathologica Communications
issn 2051-5960
publishDate 2020-11-01
url http://link.springer.com/article/10.1186/s40478-020-01056-8
work_keys_str_mv AT cantin ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT atauziedeespariat ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT madebily ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT dcastel ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT jgrill ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT mpages ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT oayrault ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT fchretien ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT agareton ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT fandreiuolo ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT elechapt ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
AT pvarlet ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression
_version_ 1724429121920958464

Similar Items